0 Comentários
0 Compartilhamentos
555 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Advances in Skin Cancer Therapies Fueling Market GrowthResearch collaborations between biotechnology firms and healthcare institutions are increasing.Joint innovation efforts are accelerating therapeutic advancements. The Basal Cell Carcinoma Treatment Market is expected to register a CAGR of 9.3% from 2025 to 2031, with market size rising from US$ XX million in 2024 to US$ XX Million by 2031. The market reflects strong clinical demand driven by...0 Comentários 0 Compartilhamentos 573 Visualizações 0 Anterior
-
Advancing Oncology Therapeutics: Anti - Neoplastic Agents Market Trends, Opportunities, and Strategic Outlook (2026–2034)The Anti - Neoplastic Agents Market is experiencing notable growth as the global fight against cancer intensifies. Increasing incidence of various cancers, combined with advancements in treatment technologies, is driving the demand for innovative anti - neoplastic therapies. These agents are fundamental to cancer treatment as they inhibit the growth and spread of malignant cells, making them...0 Comentários 0 Compartilhamentos 178 Visualizações 0 Anterior
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comentários 0 Compartilhamentos 122 Visualizações 0 Anterior
-
Emerging Therapies Transforming the Sarcoma Drugs IndustryImmunotherapy is emerging as a promising treatment approach.Checkpoint inhibitors are being evaluated for sarcoma cases.Combination therapies are improving patient survival outcomes. The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...0 Comentários 0 Compartilhamentos 794 Visualizações 0 Anterior
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comentários 0 Compartilhamentos 12 Visualizações 0 Anterior
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Comentários 0 Compartilhamentos 195 Visualizações 0 Anterior
-
Rising Demand for Precision Oncology Boosting Sarcoma Drugs Market GrowthAdvancements in precision medicine are positively influencing the Sarcoma Drugs Market. Personalized therapies are helping physicians deliver more effective treatments for sarcoma patients. This approach is expected to drive significant market growth over the forecast period. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from...0 Comentários 0 Compartilhamentos 719 Visualizações 0 Anterior
-
Unpacking Oncology Small Molecule Drugs Market Growth, Opportunities, Drivers, Strategies, Trends, and Forecast to 2031The Oncology Small Molecule Drugs Market is experiencing significant evolution as stakeholders across the pharmaceutical and biotechnology landscape intensify innovation efforts to address the growing global cancer burden. According to the Oncology Small Molecule Drugs Market report by The Insight Partners, the market is projected to grow at a compound annual growth rate (CAGR) of 5.6% from...0 Comentários 0 Compartilhamentos 281 Visualizações 0 Anterior